Evidence review

BPC-157 research

BPC-157 has a broad preclinical literature but exceptionally sparse human evidence. A two-participant safety report cannot establish clinical safety or efficacy.

Human evidence is thin

The located intravenous safety report included only two participants.

Animal work is not confirmation

Repair and signaling findings in laboratory models require controlled human replication.

Key trials are unresolved

A registered hamstring-strain trial represents ongoing research, not a published efficacy result.

Evidence map

Preclinical studies examine signaling, pharmacokinetics, and tissue-repair outcomes. Human research is not yet large or controlled enough to validate the common therapeutic claims made online.

What would materially change confidence

Controlled dose-ranging and pharmacokinetic studies in humans.
Randomized trials with objective structural and functional endpoints.
Larger safety samples with adequate follow-up.